octanoylcarnitine has been researched along with s-adenosylmethionine in 13 studies
Studies (octanoylcarnitine) | Trials (octanoylcarnitine) | Recent Studies (post-2010) (octanoylcarnitine) | Studies (s-adenosylmethionine) | Trials (s-adenosylmethionine) | Recent Studies (post-2010) (s-adenosylmethionine) |
---|---|---|---|---|---|
86 | 1 | 30 | 1,179 | 72 | 814 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (23.08) | 29.6817 |
2010's | 10 (76.92) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carpenter, K; Heath, D; Sim, KG; Wilcken, B; Wiley, V | 1 |
Lehotay, DC; LePage, J; Rockman-Greenberg, C; Thompson, JR | 1 |
Busch, U; Fingerhut, R; Liebl, B; Maier, EM; Muntau, AC; Nennstiel-Ratzel, U; Olgemöller, B; Pongratz, J; Roscher, AA; Röschinger, W | 1 |
Chace, DH; De Jesús, VR; Hannon, WH; Lim, TH; Mei, JV | 1 |
Meadows, JA; Wargo, MJ | 1 |
Moretti, S; Naccarato, A; Sindona, G; Tagarelli, A | 1 |
Hankemeier, T; Lindenburg, PW; Oedit, A; Schoonen, JW; van Duinen, V; Vulto, P | 1 |
Hagar, A; Hall, PL; Wittenauer, A | 1 |
Andrew, B; Bezuidenhout, N; George, S; Maarman, G; Madlala, HP; Mendham, A; Ojuka, E; Osiki, PO | 1 |
Aukrust, P; Berge, RK; Damås, JK; Flo, TH; Landrø, L; Svardal, A; Ueland, T; Waagsbø, B; Øktedalen, O | 1 |
Al Rijjal, D; Batchuluun, B; Bhattacharjee, A; Burdett, E; Eversley, JA; Gunderson, EP; Liu, Y; Mohan, H; Prentice, KJ; Wheeler, MB | 1 |
Bosch, AM; de Vries, M; Derks, TGJ; Gozalbo, ER; Jager, EA; Kuijpers, MM; Mulder, MF; Schielen, PCJI; van Spronsen, FJ; Visser, G; Waterham, HR; Williams, M | 1 |
Bovet, C; Gray, PC; Kruithof-de Julio, M; Minoli, M; Ng, CKY; Piscuoglio, S; Spahn, M; Thalmann, GN; Wehrhan, A; Zoni, E | 1 |
1 review(s) available for octanoylcarnitine and s-adenosylmethionine
Article | Year |
---|---|
Measurement of β-oxidation capacity of biological samples by respirometry: a review of principles and substrates.
Topics: Acyl Coenzyme A; Carnitine; Coenzyme A; Electrodes; Fatty Acids; Feedback, Physiological; Humans; Malates; Mitochondria; Oxidation-Reduction; Oxidative Phosphorylation; Oxygen Consumption; Palmitoylcarnitine | 2016 |
12 other study(ies) available for octanoylcarnitine and s-adenosylmethionine
Article | Year |
---|---|
Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies.
Topics: Acyl-CoA Dehydrogenase; Acyl-CoA Dehydrogenases; Australian Capital Territory; Carnitine; Humans; Infant, Newborn; Mass Spectrometry; Mutation; Neonatal Screening; New South Wales; Prospective Studies; Retrospective Studies | 2001 |
Blood acylcarnitine levels in normal newborns and heterozygotes for medium-chain acyl-CoA dehydrogenase deficiency: a relationship between genotype and biochemical phenotype?
Topics: Acyl-CoA Dehydrogenase; Adenine; Carnitine; Diagnosis, Differential; Gene Frequency; Genotype; Guanine; Heterozygote; Humans; Infant, Low Birth Weight; Infant, Newborn; Metabolism, Inborn Errors; Osmolar Concentration; Phenotype | 2004 |
Dissection of biochemical borderline phenotypes in carriers and genetic variants of medium-chain acyl-CoA dehyrogenase deficiency: implications for newborn screening [corrected].
Topics: Carnitine; Case-Control Studies; Heterozygote; Humans; Infant, Newborn; Lipid Metabolism, Inborn Errors; Mutation; Neonatal Screening | 2009 |
Comparison of amino acids and acylcarnitines assay methods used in newborn screening assays by tandem mass spectrometry.
Topics: Amino Acids; Butanols; Carnitine; Humans; Infant, Newborn; Leucine; Metabolic Diseases; Methionine; Neonatal Screening; Palmitoylcarnitine; Phenylalanine; Quality Control; Tandem Mass Spectrometry | 2010 |
Characterization of Pseudomonas aeruginosa growth on O-acylcarnitines and identification of a short-chain acylcarnitine hydrolase.
Topics: Blotting, Western; Carboxylic Ester Hydrolases; Carnitine; Computational Biology; DNA Primers; Electrophoresis, Polyacrylamide Gel; Enzyme Induction; Genetic Vectors; Hydrolysis; Polymerase Chain Reaction; Pseudomonas aeruginosa; Type C Phospholipases | 2013 |
Identification and assay of underivatized urinary acylcarnitines by paper spray tandem mass spectrometry.
Topics: Adult; Calibration; Carnitine; Humans; Limit of Detection; Paper; Reproducibility of Results; Tandem Mass Spectrometry; Young Adult | 2013 |
Continuous-flow microelectroextraction for enrichment of low abundant compounds.
Topics: Carnitine; Chromatography, Reverse-Phase; Electrochemical Techniques; Equipment Design; Humans; Laurates; Limit of Detection; Mass Spectrometry; Solid Phase Extraction | 2014 |
Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: performance improvement by monitoring a new ratio.
Topics: Acyl-CoA Dehydrogenase; Acyl-CoA Dehydrogenases; Biomarkers; Carnitine; False Positive Reactions; Heterozygote; Humans; Infant; Infant, Newborn; Infant, Very Low Birth Weight; Lipid Metabolism, Inborn Errors; Neonatal Screening; United States | 2014 |
Low levels of short- and medium-chain acylcarnitines in HIV-infected patients.
Topics: Adult; Antiretroviral Therapy, Highly Active; Carnitine; Case-Control Studies; Disease Progression; Female; HIV Infections; Humans; Interferon-gamma; Interferon-gamma Release Tests; Longitudinal Studies; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Tumor Necrosis Factor-alpha | 2016 |
Elevated Medium-Chain Acylcarnitines Are Associated With Gestational Diabetes Mellitus and Early Progression to Type 2 Diabetes and Induce Pancreatic β-Cell Dysfunction.
Topics: Adult; Animals; Carnitine; Case-Control Studies; Cell Respiration; Diabetes Mellitus, Type 2; Diabetes, Gestational; Disease Progression; Female; Glucose Intolerance; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Islets of Langerhans; Mice; Postpartum Period; Pregnancy | 2018 |
A nationwide retrospective observational study of population newborn screening for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in the Netherlands.
Topics: Acyl-CoA Dehydrogenase; Carnitine; Female; Genotype; Humans; Infant, Newborn; Lipid Metabolism, Inborn Errors; Male; Neonatal Screening; Netherlands; Prevalence; Retrospective Studies | 2019 |
Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification.
Topics: Aged; Carnitine; Case-Control Studies; Chromatography, Liquid; Disease Progression; Fatty Acids; Humans; Male; Mass Spectrometry; Metabolomics; Middle Aged; Prognosis; Prostatic Neoplasms; White People | 2019 |